PA
CVS icon

Promethium Advisors’s CVS Health CVS Stock Holding History

Promethium Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,480
Closed -$236K – 116
2025
Q1 		$236K Buy
+3,480
New +$208K 0.15% 105
2024
Q4 		– Sell
-13,205
Closed -$830K – 130
2024
Q3 		$830K Buy
+13,205
New +$770K 0.59% 51

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Promethium Advisors's CVS Position: Q2 2025 in Review

Promethium Advisors sold out of CVS Health (CVS) in Q2 2025, closing a stake of 3,480 shares — an estimated $236K sold.

Promethium Advisors first reported a position in CVS in Q3 2024 and held it in 2 quarters. The position peaked at $830K in Q3 2024. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Promethium Advisors reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Promethium Advisors sold 3,480 CVS Health shares in Q2 2025, an estimated $236K.
  • Promethium Advisors first reported a position in CVS Health in Q3 2024 and held it in 2 quarters.
  • Promethium Advisors's CVS Health position peaked at $830K in Q3 2024.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Promethium Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.